Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey
Launched by FONDAZIONE IRCCS POLICLINICO SAN MATTEO DI PAVIA · Mar 7, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. \>18 years of age;
- • 2. Oncology patient defined as a patient with solid tumors undergoing active systemic treatment or follow-up;
- • 3. Written informed consent
- Exclusion Criteria:
- • 1. Patients with hematological tumors
- • 2. Patients who are unable to understand informed consent document
About Fondazione Irccs Policlinico San Matteo Di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia is a prestigious research hospital and clinical trial sponsor located in Italy, dedicated to advancing medical knowledge and improving patient care through innovative research. As a leading institution in the fields of clinical and translational medicine, the foundation actively conducts trials across various therapeutic areas, emphasizing rigorous scientific methodologies and adherence to ethical standards. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, Fondazione IRCCS Policlinico San Matteo serves as a pivotal contributor to the development of new treatments and healthcare solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavia, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported